Diabetes, Obesity and Metabolism

Dyslipidaemia in diabetic patients: time for a rethink
pp. 609-616(8)
Author: Shepherd,

The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus
pp. 617-629(13)
Authors: Mathur,; Noronha,; Rodrigues,; Davis,

Premixed insulin treatment for type 2 diabetes: analogue or human?
pp. 630-639(10)
Authors: Garber, Alan J.; Ligthelm, Robert; Christiansen, Jens S.; Liebl, Andreas

Effects of pioglitazone on lipid and lipoprotein metabolism
pp. 640-647(8)
Author: Betteridge, D. John

Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies
pp. 648-659(12)
Authors: Heise,; Pieber,

The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis
pp. 660-668(9)
Authors: Panagiotakos,; Pitsavos,; Das,; Skoumas,; Stefanadis,

The effects of underfeeding on whole-body carbohydrate partitioning, thermogenesis and uncoupling protein 3 expression in human skeletal muscle
pp. 669-678(10)
Authors: Seevaratnam,; Bennett,; Webber,; Macdonald,

Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome
pp. 679-687(9)
Authors: Trenell,; Ward,; Yee,; Phillips,; Kemp,; Grunstein,; Thompson,

Diet-induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse hearts
pp. 688-696(9)
Authors: Bender,; Herrick,; Lott,; Klabunde,

Acute hyperglycaemia does not alter coronary vascular function in isolated, perfused rat hearts
pp. 697-705(9)
Authors: Klabunde,; Ryan,; Paxson,

Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK
pp. 706-713(8)
Authors: Davies,; Evans,; Storms,; Gomis,; Khunti,

Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone
pp. 714-723(10)
Authors: Nadeau,; Ehlers,; Aguirre,; Reusch,; Draznin,

Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes
pp. 724-732(9)
Authors: Bebakar,; Chow,; Kadir,; Suwanwalaikorn,; Vaz,; Bech,

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
pp. 733-745(13)
Authors: Hermansen,; Kipnes,; Luo,; Fanurik,; Khatami,; Stein,

Insulin glulisine: a faster onset of action compared with insulin lispro
pp. 746-753(8)
Authors: Heise,; Nosek,; Spitzer,; Heinemann,; Niemöller,; Frick,; Becker,

A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes
pp. 754-755(2)
Author: Meneilly,

Association of serum caffeine concentrations with serum glucose levels in caffeine-drug users and non-users - results of German National Health Surveys
pp. 756-758(3)

Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity
pp. 759-761(3)

Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity
pp. 761-763(3)

News and Views
pp. 764-766(3)
Author: Holt, Richard I. G.